The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems

Инициатива IDeaS: пилотное исследование для оценки влияния редких заболеваний на пациентов и системы здравоохранения
Melissa Anne Haendel, Joni L. Rutter, Christine M. Cutillo, Hugh J. S. Dawkins, David A. Pearce, Bryan J. Laraway, Ainslie Tisdale, Ramaa Nathan, Pierantonio A. Russo, Douglas Nowak, Cindy Hasche, Chun‐Hung Chan, Emily R. Griese, Oodaye Shukla, Anne Pariser
2021-10-22

diagnostic journeydirect medical costshealthcare systemsmachine learningrare diseases
BACKGROUND: Rare diseases (RD) are a diverse collection of more than 7-10,000 different disorders, most of which affect a small number of people per disease. Because of their rarity and fragmentation of patients across thousands of different disorders, the medical needs of RD patients are not well recognized or quantified in healthcare systems (HCS). METHODOLOGY: We performed a pilot IDeaS study, where we attempted to quantify the number of RD patients and the direct medical costs of 14 representative RD within 4 different HCS databases and performed a preliminary analysis of the diagnostic journey for selected RD patients. RESULTS: The overall findings were notable for: (1) RD patients are difficult to quantify in HCS using ICD coding search criteria, which likely results in under-counting and under-estimation of their true impact to HCS; (2) per patient direct medical costs of RD are high, estimated to be around three-fivefold higher than age-matched controls; and (3) preliminary evidence shows that diagnostic journeys are likely prolonged in many patients, and may result in progressive, irreversible, and costly complications of their disease CONCLUSIONS: The results of this small pilot suggest that RD have high medical burdens to patients and HCS, and collectively represent a major impact to the public health. Machine-learning strategies applied to HCS databases and medical records using sentinel disease and patient characteristics may hold promise for faster and more accurate diagnosis for many RD patients and should be explored to help address the high unmet medical needs of RD patients.
1
Direct medical costs per rare disease patient are estimated to be approximately three- to fivefold higher than those of age-matched controls.
2
Machine-learning approaches using sentinel diseases and patient characteristics may enable faster, more accurate rare disease diagnosis and merit further investigation.
3
Preliminary evidence indicates that diagnostic journeys are prolonged for many rare disease patients, potentially causing progressive, irreversible, and costly complications.
4
Rare disease patients are difficult to identify using ICD coding in healthcare-system databases, likely causing substantial undercounting and impact underestimation.
5
The pilot study found that rare diseases collectively impose a major medical burden on patients and healthcare systems, despite affecting few people per individual disorder.

Patients with rare diseases and the healthcare systems caring for them

The quantification of rare-disease prevalence, direct medical costs, diagnostic journeys, and overall burden on patients and healthcare systems

Publication Details
Publication Date
2021-10-22
Journal
Publisher
ISSN
Cited by
104
Access Type
Author Information
Authors
Melissa Anne Haendel
Joni L. Rutter
Christine M. Cutillo
Hugh J. S. Dawkins
David A. Pearce
Bryan J. Laraway
Ainslie Tisdale
Ramaa Nathan
Pierantonio A. Russo
Douglas Nowak
Cindy Hasche
Chun‐Hung Chan
Emily R. Griese
Oodaye Shukla
Anne Pariser
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%